Apigenin
Research / preclinicalFlavone CD38 inhibitor — boosts NAD+ via different pathway than NMN/NR.
Mechanism
CD38 inhibitor. Flavone CD38 inhibitor — boosts NAD+ via different pathway than NMN/NR. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (2)
Apigenin Inhibits CD38 and Boosts NAD+ Levels
Identified apigenin as CD38 inhibitor with NAD+ effects.
PubMed PMID 23209187 →Apigenin: A Promising Molecule for Cancer Prevention
Reviewed apigenin pharmacology and cancer chemoprevention.
PubMed PMID 20309632 →